Robeco Schweiz AG Buys 13,915 Shares of Colgate-Palmolive Company (NYSE:CL)

Robeco Schweiz AG lifted its stake in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 53.3% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 40,003 shares of the company's stock after buying an additional 13,915 shares during the quarter. Robeco Schweiz AG's holdings in Colgate-Palmolive were worth $3,748,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently modified their holdings of CL. Westend Capital Management LLC grew its position in Colgate-Palmolive by 111.1% in the 1st quarter. Westend Capital Management LLC now owns 266 shares of the company's stock valued at $25,000 after purchasing an additional 140 shares during the period. Cornerstone Planning Group LLC grew its position in Colgate-Palmolive by 1,913.3% in the 1st quarter. Cornerstone Planning Group LLC now owns 302 shares of the company's stock valued at $28,000 after purchasing an additional 287 shares during the period. Vermillion Wealth Management Inc. acquired a new stake in Colgate-Palmolive in the 4th quarter valued at $31,000. Wintrust Investments LLC acquired a new stake in Colgate-Palmolive in the 4th quarter valued at $33,000. Finally, Bernard Wealth Management Corp. purchased a new position in Colgate-Palmolive during the 4th quarter worth $33,000. Institutional investors and hedge funds own 80.41% of the company's stock.

Analyst Ratings Changes

A number of research firms have issued reports on CL. Wells Fargo & Company lifted their price objective on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the stock an "underweight" rating in a report on Wednesday, April 2nd. Citigroup lifted their price objective on shares of Colgate-Palmolive from $103.00 to $108.00 and gave the stock a "buy" rating in a report on Monday, April 28th. Piper Sandler cut their price objective on shares of Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating on the stock in a report on Monday, March 31st. Barclays cut their price objective on shares of Colgate-Palmolive from $89.00 to $86.00 and set an "equal weight" rating on the stock in a report on Friday, April 11th. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Colgate-Palmolive from $95.00 to $103.00 and gave the stock an "overweight" rating in a report on Monday, April 28th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and eight have issued a buy rating to the company's stock. According to data from MarketBeat, Colgate-Palmolive currently has an average rating of "Hold" and an average target price of $101.13.

Colgate-Palmolive Stock Performance

Colgate-Palmolive stock traded down $1.02 during midday trading on Friday, reaching $89.60. The stock had a trading volume of 4,372,701 shares, compared to its average volume of 4,849,733. The firm's 50-day moving average price is $90.64 and its 200 day moving average price is $90.54. Colgate-Palmolive Company has a 12 month low of $85.32 and a 12 month high of $109.30. The firm has a market capitalization of $72.61 billion, a PE ratio of 25.31, a P/E/G ratio of 4.80 and a beta of 0.37. The company has a quick ratio of 0.54, a current ratio of 0.85 and a debt-to-equity ratio of 8.96.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its quarterly earnings results on Friday, April 25th. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.86 by $0.05. Colgate-Palmolive had a return on equity of 461.04% and a net margin of 14.52%. The firm had revenue of $4.91 billion for the quarter, compared to analysts' expectations of $4.92 billion. During the same period in the prior year, the business posted $0.86 earnings per share. The company's revenue was down 3.0% on a year-over-year basis. As a group, research analysts predict that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive announced that its Board of Directors has authorized a stock buyback plan on Thursday, March 20th that authorizes the company to buyback $5.00 billion in outstanding shares. This buyback authorization authorizes the company to purchase up to 6.8% of its stock through open market purchases. Stock buyback plans are typically an indication that the company's leadership believes its stock is undervalued.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, August 15th. Stockholders of record on Friday, July 18th will be given a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a dividend yield of 2.32%. The ex-dividend date is Friday, July 18th. Colgate-Palmolive's dividend payout ratio is presently 58.76%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.